Erica L Goodrich

7PUBLICATIONS
36CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedCardiology (incl. cardiovascular diseases)Exercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 29, 2026
Prior anticoagulation experience and bleeding risk with the factor XI inhibitor abelacimab in the AZALEA-TIMI 71 study.

|Jun 23, 2025
Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 Trial.

Samer Al Said, Siddharth M Patel, Robert P Giugliano

|Jul 20, 2022
Epidemiology of heart failure hospitalization in patients with stable atherothrombotic disease: Insights from the TRA 2°P-TIMI 50 trial.

Benjamin L Freedman, David D Berg, Benjamin M Scirica

|May 05, 2022
Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial.

Remo H M Furtado, Itamar Raz, Erica L Goodrich

|Apr 26, 2022
Epidemiology and Management of ST-Segment-Elevation Myocardial Infarction in Patients With COVID-19: A Report From the American Heart Association COVID-19 Cardiovascular Disease Registry.

Ankeet S Bhatt, Anubodh S Varshney, Erica L Goodrich

|Oct 08, 2021
Efficacy and Safety of Vorapaxar by Intensity of Background Lipid-Lowering Therapy in Patients With Peripheral Artery Disease: Insights From the TRA2P-TIMI 50 Trial.

Ian C Gilchrist, David A Morrow, Mark A Creager

Pageof 2

Frequent Collaborators

4 joint publications

David A Morrow

3 joint publications

Marc S Sabatine

2 joint publications

Shaun G Goodman

2 joint publications

Boyoung Joung